Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'R24' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 12 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skog, ALH; Wadhwa, M; Hassan, M; Gharizadeh, B; Bird, C; Ragnhammar, P; Thorpe, R; Mellstedt, H
      Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2

      CLINICAL CANCER RESEARCH
    2. Fiedler, W; Kruger, W; Laack, E; Mende, T; Vohwinkel, G; Hossfeld, DK
      A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients withadvanced colorectal cancer

      ONCOLOGY REPORTS
    3. Scott, AM; Lee, FT; Hopkins, W; Cebon, JS; Wheatley, JM; Liu, ZQ; Smyth, FE; Murone, C; Sturrock, S; MacGregor, D; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, MW; Davis, ID; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, G; Ritter, G; Hoffman, EW; Burgess, AW; Old, LJ
      Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial

      JOURNAL OF CLINICAL ONCOLOGY
    4. Coral, S; Fonsatti, E; Sigalotti, L; De Nardo, C; Visintin, A; Nardi, G; Colizzi, F; Colombo, MP; Romano, G; Altomonte, M; Maio, M
      Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement

      JOURNAL OF CELLULAR PHYSIOLOGY
    5. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    6. MAGUIRE HC; BERD D; LATTIME EC; MCCUE PA; KIM S; CHAPMAN PB; MASTRANGELO MJ
      PHASE-I STUDY OF R24 IN PATIENTS WITH METASTATIC MELANOMA INCLUDING EVALUATION OF IMMUNOLOGICAL PARAMETERS

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    7. ATKINS MB
      IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA

      Hematology/oncology clinics of North America
    8. NASI ML; MEYERS M; LIVINGSTON PO; HOUGHTON AN; CHAPMAN PB
      ANTIMELANOMA EFFECTS OF R24, A MONOCLONAL-ANTIBODY AGAINST GD(3) GANGLIOSIDE

      Melanoma research
    9. ORTALDO JR; MASON AT; LONGO DL; BECKWITH M; CREEKMORE SP; MCVICAR DW
      T-CELL ACTIVATION VIA THE DISIALOGANGLIOSIDE GD3 - ANALYSIS OF SIGNAL-TRANSDUCTION

      Journal of leukocyte biology
    10. CHACHOUA A; ORATZ R; LIEBES L; ALTER RS; FELICE A; PEACE D; VILCEK J; BLUM RH
      PHASE IB TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMBINED WITH MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATICMELANOMA

      Journal of immunotherapy with emphasis on tumor immunology
    11. BUKOWSKI RM; MURTHY SA; FINKE J; CAULFIELD MJ; TUBBS R; HERZOG P; STANLEY J; EDINGER M; TUASON L; MCLAIN D; BUDD GT; OLENCKI T; GANAPATHI R
      PHASE-I TRIAL OF CISPLATIN, WR-2721, AND THE MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND BIOLOGIC EFFECTS

      Journal of immunotherapy with emphasis on tumor immunology
    12. CHAPMAN PB; GILLIES SD; HOUGHTON AN; REILLY RM
      MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY

      Cancer immunology and immunotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 06:30:52